Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nocturnal blood pressure burden: towards a better understanding of the OSA-hypertension relationship.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same author

OSA in the aging population: Diagnostic and therapeutic considerations.

Sleep medicine reviews·2026
Same author

Real-life use of bronchodilators and inhaled corticosteroids in cystic fibrosis and non-CF bronchiectasis, Do guidelines matter?

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2025
Same author

Biochemical characteristics of inhaled antibiotics related to tolerability.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2025
Same author

Biochemical characteristics of inhaled antibiotics related to tolerability.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2025
Same author

Archivos de Bronconeumología: 60 Years and Going on.

Archivos de bronconeumologia·2024

Related Experiment Video

Updated: Jun 24, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

[Bronchiectasis treatment in adults].

Miguel Angel Martínez García1, Luis Máiz Carro, Javier de Gracia Roldán

  • 1Unidad de Neumología, Servicio de Medicina Interna, Hospital General de Requena, Valencia, España. miangel@comv.es

Medicina Clinica
|April 14, 2009
PubMed
Summary

Bronchiectasis, a condition of bronchial wall dilation, is increasingly diagnosed and impacts patient quality of life. Treatment involves addressing the cause, infections, secretions, inflammation, and complications.

Area of Science:

  • Pulmonology
  • Internal Medicine

Context:

  • Bronchiectasis is defined by bronchial wall dilation and destruction.
  • Increased diagnoses stem from rising chronic diseases and advanced diagnostic tools.
  • The condition negatively affects patient quality of life, lung function, and disease prognosis.

Purpose:

  • To outline the multifaceted treatment approach for adult bronchiectasis.
  • To highlight the eight fundamental pillars of bronchiectasis management.

Summary:

  • Treatment addresses the underlying etiology when known.
  • Management includes combating microbial colonization (e.g., Pseudomonas aeruginosa) with antibiotics.
  • Key interventions involve secretion clearance (physiotherapy, mucolytics), inflammation control (inhaled steroids, macrolides), and managing hyperresponsiveness (bronchodilators).

Related Experiment Videos

Last Updated: Jun 24, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

  • Systemic issues like malnutrition, exacerbations, and complications (hemoptysis, respiratory failure) require specific treatments.
  • Surgical options like lung transplantation or resection are also considered.

    • Impact:

    • Effective management improves patient quality of life and lung function.
    • Comprehensive treatment strategies are crucial for a better prognosis in bronchiectasis patients.
    • Understanding these pillars aids clinicians in providing optimal patient care.